Advertisement

Oncology

Advertisement

Josh Carpenter, PhD, has been named vice president and chief integration officer at Tampa, Fla.-based Moffitt Cancer Center, and president of Speros, a Land O' Lakes, Fla.-based research facility and medical campus owned by the cancer center.

Researchers from the University of Texas Health Science Center at San Antonio have developed a drug that more than doubled median survival time and progression-free time for patients with glioblastoma during a clinical trial.

Advertisement